ChartRow logo
ChartRow
Stocks and ETFs

financial statements

The full income statement, balance sheet, and cash-flow statement for Biogen Inc. (BIIB), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

See the live BIIB chart & snapshot →

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
9.89B
YoY+2.2%
9.68B
YoY-1.6%
9.84B
YoY-3.3%
10.2B
YoY-7.4%
11.0B
YoY-18.3%
Cost of revenue
2.40B
YoY+4.1%
2.31B
YoY-8.8%
2.53B
YoY+11.2%
2.28B
YoY+8.0%
2.11B
YoY+16.9%
Research & development
1.78B
YoY-10.2%
1.98B
YoY-19.0%
2.45B
YoY+9.6%
2.23B
YoY-10.8%
2.50B
YoY-37.3%
Selling, general & administrative
2.43B
YoY+1.2%
2.40B
YoY-5.7%
2.55B
YoY+6.1%
2.40B
YoY-10.1%
2.67B
YoY+6.8%
Restructuring
48.6M
YoY+60.9%
30.2M
YoY-86.2%
219M
YoY+66.9%
131M
0.00
Amortization of intangibles
507M
YoY+31.2%
387M
YoY+60.6%
241M
YoY-2.3%
246M
YoY-2.3%
252M
YoY-1.2%
Operating income
2.84B
YoY-37.6%
Interest expense
268M
YoY+6.9%
250M
YoY+1.4%
247M
YoY+0.1%
247M
YoY-2.8%
254M
YoY+14.0%
Interest & investment income
125M
YoY+84.9%
67.6M
YoY-75.6%
277M
YoY+209.6%
89.3M
YoY+711.8%
11.0M
YoY-73.8%
Other non-operating income
-24.7M
YoY-848.5%
3.30M
YoY+925.0%
-400K
YoY-104.0%
10.1M
YoY+80.4%
5.60M
YoY+293.1%
Equity-method income
0.00
0.00
YoY-100.0%
2.60M
YoY-92.6%
34.9M
YoY+957.6%
Pre-tax income
1.56B
YoY-18.3%
1.91B
YoY+47.0%
1.30B
YoY-63.9%
3.59B
YoY+105.8%
1.75B
YoY-65.4%
Income tax
264M
YoY-3.7%
274M
YoY+102.4%
135M
YoY-78.6%
633M
YoY+1105.3%
52.5M
YoY-94.7%
1.29B
YoY-20.8%
1.63B
YoY+40.6%
1.16B
YoY-61.9%
3.05B
YoY+95.8%
1.56B
YoY-61.1%
$8.79
YoY-21.4%
$11.18
YoY+40.3%
$7.97
YoY-61.8%
$20.87
YoY+100.7%
$10.40
YoY-58.1%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
8.97B
YoY+20.3%
7.46B
YoY+8.7%
6.86B
YoY-29.9%
9.79B
YoY+24.6%
7.86B
YoY+14.1%
29.4B
YoY+5.0%
28.0B
YoY+4.5%
26.8B
YoY+9.3%
24.6B
YoY+2.8%
23.9B
YoY-3.0%
3.35B
YoY-39.4%
5.53B
YoY+61.0%
3.43B
YoY+4.9%
3.27B
YoY-23.9%
4.30B
YoY+14.9%
11.2B
YoY-1.3%
11.3B
YoY-5.9%
12.0B
YoY+7.9%
11.2B
YoY-13.6%
12.9B
YoY-7.3%
18.3B
YoY+9.2%
16.7B
YoY+13.0%
14.8B
YoY+10.5%
13.4B
YoY+23.0%
10.9B
YoY+1.8%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
2.20B
YoY-23.3%
2.88B
YoY+85.9%
1.55B
YoY+11.8%
1.38B
YoY-62.0%
3.64B
YoY-13.9%
-1.37B
YoY-71.6%
-799M
YoY+80.5%
-4.10B
YoY-360.1%
1.58B
YoY+379.7%
-564M
YoY+7.4%
-302M
YoY+55.8%
-684M
YoY-557.8%
149M
YoY+108.5%
-1.75B
YoY+16.2%
-2.09B
YoY+60.4%
FX effect on cash
102M
YoY+250.5%
-67.7M
YoY-292.9%
35.1M
YoY+163.0%
-55.7M
YoY+6.9%
-59.8M
YoY-186.7%
Interest paid
264M
YoY+7.6%
245M
YoY-2.7%
252M
YoY-3.9%
263M
YoY-6.5%
281M
YoY+3.0%
Income taxes paid
864M
YoY+143.3%
355M
YoY-52.1%
741M
YoY-20.6%
933M
YoY+276.3%
248M
YoY-72.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
25.8B
YoY+15.9%
22.3B
YoY-40.6%
37.5B
YoY-6.0%
39.9B
YoY+13.1%
35.2B
YoY-6.5%
P/E
20.0×
YoY+46.2%
13.7×
YoY-46.7%
25.6×
YoY+82.7%
14.0×
YoY-38.1%
22.6×
YoY+140.5%
P/S
2.6×
YoY+13.3%
2.3×
YoY-38.6%
3.8×
YoY-3.3%
3.9×
YoY+20.8%
3.2×
YoY+14.5%
P/B
1.4×
YoY+6.1%
1.3×
YoY-48.5%
2.6×
YoY-17.7%
3.1×
YoY-2.7%
3.2×
YoY-8.1%
P/FCF
12.6×
YoY+53.8%
8.2×
YoY-76.8%
35.3×
YoY+92.6%
18.3×
YoY+75.9%
10.4×
YoY+5.2%
Earnings yield
5.0%
YoY-31.6%
7.3%
YoY+87.7%
3.9%
YoY-45.3%
7.1%
YoY+61.5%
4.4%
YoY-58.4%
FCF yield
7.9%
YoY-35.0%
12.2%
YoY+331.2%
2.8%
YoY-48.1%
5.5%
YoY-43.2%
9.6%
YoY-5.0%
Source filing10-K10-K10-K10-K10-K

About this data

Source: BIIB's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BIIB filings on SEC EDGAR → Not investment advice.